Drug
Fucoidan
Fucoidan is a pharmaceutical drug with 7 clinical trials. Currently 4 active trials ongoing.
Total Trials
7
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(57%)
Phase Distribution
Ph not_applicable
6
86%
Ph phase_2
1
14%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
7
all time
Status Distribution
Active(4)
Other(3)
Detailed Status
Recruiting4
unknown3
Development Timeline
Analytics
Development Status
Total Trials
7
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (14.3%)
N/A6 (85.7%)
Trials by Status
unknown343%
recruiting457%
Recent Activity
4 active trials
Showing 5 of 7
recruitingnot_applicable
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07045896
recruitingnot_applicable
Project SIRT6 Activator
NCT07500649
recruitingnot_applicable
PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)
NCT07451496
recruitingphase_2
A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
NCT04597476
unknownnot_applicable
Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis
NCT05437887
Clinical Trials (7)
Showing 7 of 7 trials
NCT07045896Not Applicable
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07500649Not Applicable
Project SIRT6 Activator
NCT07451496Not Applicable
PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)
NCT04597476Phase 2
A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
NCT05437887Not Applicable
Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis
NCT05623852Not Applicable
The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia
NCT05616507Not Applicable
Oligo-Fucoidan Decrease Lung Radiation Damage
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7